Neuronetics, Inc.
US ˙ NasdaqGM ˙ US64131A1051

Introduction

This page provides a comprehensive analysis of the known insider trading history of William Andrew Macan. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate William Andrew Macan has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:STIM / Neuronetics, Inc. EVP, GC, CCO and CS 526,805
US:SLCA / U.S. Silica Holdings, Inc. SVP General Counsel 13,888
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by William Andrew Macan. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases STIM / Neuronetics, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in STIM / Neuronetics, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2020-03-10 STIM MACAN WILLIAM ANDREW 5,000 2.0000 5,000 2.0000 10,000 318 21.27 96,350 963.50

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

STIM / Neuronetics, Inc. Insider Trades
Insider Sales STIM / Neuronetics, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in STIM / Neuronetics, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2025-03-04 STIM MACAN WILLIAM ANDREW 377 4.4800 377 4.4800 1,689 182 3.1400 -504 -29.87
2025-02-14 STIM MACAN WILLIAM ANDREW 18,965 4.1100 18,965 4.1100 77,946
2025-02-12 STIM MACAN WILLIAM ANDREW 12,175 3.8300 12,175 3.8300 46,630
2025-02-10 STIM MACAN WILLIAM ANDREW 1,970 3.2800 1,970 3.2800 6,462
2024-10-08 STIM MACAN WILLIAM ANDREW 1,541 0.8200 1,541 0.8200 1,264
2024-02-29 STIM MACAN WILLIAM ANDREW 6,026 2.9400 6,026 2.9400 17,716
2024-02-28 STIM MACAN WILLIAM ANDREW 22,377 3.1600 22,377 3.1600 70,711
2024-02-14 STIM MACAN WILLIAM ANDREW 15,621 3.3800 15,621 3.3800 52,799
2024-02-06 STIM MACAN WILLIAM ANDREW 5,385 3.3900 5,385 3.3900 18,255
2023-10-06 STIM MACAN WILLIAM ANDREW 1,469 1.1550 1,469 1.1550 1,697
2023-07-11 STIM MACAN WILLIAM ANDREW 2,645 2.1300 2,645 2.1300 5,634
2023-03-07 STIM MACAN WILLIAM ANDREW 12,692 4.5900 12,692 4.5900 58,256
2023-02-16 STIM MACAN WILLIAM ANDREW 11,044 5.9100 11,044 5.9100 65,270
2023-02-15 STIM MACAN WILLIAM ANDREW 11,974 5.9000 11,974 5.9000 70,647
2023-02-07 STIM MACAN WILLIAM ANDREW 5,162 5.9900 5,162 5.9900 30,920
2023-01-23 STIM MACAN WILLIAM ANDREW 16,046 5.9600 16,046 5.9600 95,634
2022-10-10 STIM MACAN WILLIAM ANDREW 76 2.8200 76 2.8200 214
2022-10-07 STIM MACAN WILLIAM ANDREW 1,547 2.9300 1,547 2.9300 4,533
2022-07-08 STIM MACAN WILLIAM ANDREW 2,746 3.6000 2,746 3.6000 9,886
2022-03-08 STIM MACAN WILLIAM ANDREW 137 3.1385 137 3.1385 430
2022-03-07 STIM MACAN WILLIAM ANDREW 11,489 2.8488 11,489 2.8488 32,730
2022-02-08 STIM MACAN WILLIAM ANDREW 15 3.2700 15 3.2700 49
2022-02-07 STIM MACAN WILLIAM ANDREW 4,716 3.2639 4,716 3.2639 15,393
2022-01-24 STIM MACAN WILLIAM ANDREW 11,562 3.5200 11,562 3.5200 40,698
2021-07-08 STIM MACAN WILLIAM ANDREW 2,591 14.6121 2,591 14.6121 37,860
2021-03-09 STIM MACAN WILLIAM ANDREW 8,537 14.6500 8,537 14.6500 125,067
2021-01-22 STIM MACAN WILLIAM ANDREW 12,696 21.2800 12,696 21.2800 270,171

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

STIM / Neuronetics, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by William Andrew Macan as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-03-06 2025-03-04 4 STIM Neuronetics, Inc.
Common Stock
S - Sale -377 526,805 -0.07 4.48 -1,689 2,360,086
2025-02-26 2025-02-24 4 STIM Neuronetics, Inc.
Common Stock
A - Award 157,500 527,182 42.60
2025-02-18 2025-02-14 4 STIM Neuronetics, Inc.
Common Stock
S - Sale -18,965 369,682 -4.88 4.11 -77,946 1,519,393
2025-02-14 2025-02-12 4 STIM Neuronetics, Inc.
Common Stock
S - Sale -12,175 388,647 -3.04 3.83 -46,630 1,488,518
2025-02-12 2025-02-10 4 STIM Neuronetics, Inc.
Common Stock
S - Sale -1,970 400,822 -0.49 3.28 -6,462 1,314,696
2024-10-10 2024-10-08 4 STIM Neuronetics, Inc.
Common Stock
S - Sale -1,541 402,792 -0.38 0.82 -1,264 330,289
2024-03-01 2024-02-29 4 STIM Neuronetics, Inc.
Common Stock
A - Award 15,000 404,333 3.85
2024-03-01 2024-02-29 4 STIM Neuronetics, Inc.
Common Stock
S - Sale -6,026 389,333 -1.52 2.94 -17,716 1,144,639
2024-03-01 2024-02-28 4 STIM Neuronetics, Inc.
Common Stock
S - Sale -22,377 395,359 -5.36 3.16 -70,711 1,249,334
2024-02-16 2024-02-14 4 STIM Neuronetics, Inc.
Common Stock
S - Sale -15,621 417,736 -3.60 3.38 -52,799 1,411,948
2024-02-07 2024-02-06 4 STIM Neuronetics, Inc.
Common Stock
S - Sale -5,385 433,357 -1.23 3.39 -18,255 1,469,080
2024-02-07 2024-02-05 4 STIM Neuronetics, Inc.
Common Stock
A - Award 90,000 438,742 25.81
2023-12-21 2023-12-21 4 STIM Neuronetics, Inc.
Common Stock
S - Sale X -11,663 348,742 -3.24 2.52 -29,391 878,830
2023-12-21 2023-12-20 4 STIM Neuronetics, Inc.
Common Stock
S - Sale X -11,664 360,405 -3.13 2.70 -31,493 973,094
2023-12-21 2023-12-19 4 STIM Neuronetics, Inc.
Common Stock
S - Sale X -11,664 372,069 -3.04 2.24 -26,127 833,435
2023-10-10 2023-10-06 4 STIM Neuronetics, Inc.
Common Stock
S - Sale -1,469 383,733 -0.38 1.16 -1,697 443,212
2023-07-12 2023-07-11 4 STIM Neuronetics, Inc.
Common Stock
S - Sale -2,645 385,202 -0.68 2.13 -5,634 820,480
2023-03-09 2023-03-07 4 STIM Neuronetics, Inc.
Common Stock
S - Sale -12,692 387,847 -3.17 4.59 -58,256 1,780,218
2023-02-17 2023-02-16 4 STIM Neuronetics, Inc.
Common Stock
S - Sale -11,044 400,539 -2.68 5.91 -65,270 2,367,185
2023-02-17 2023-02-15 4 STIM Neuronetics, Inc.
Common Stock
S - Sale -11,974 411,583 -2.83 5.90 -70,647 2,428,340
2023-02-09 2023-02-08 4 STIM Neuronetics, Inc.
Common Stock
A - Award 90,000 423,557 26.98
2023-02-09 2023-02-07 4 STIM Neuronetics, Inc.
Common Stock
S - Sale -5,162 333,557 -1.52 5.99 -30,920 1,998,006
2023-01-24 2023-01-23 4 STIM Neuronetics, Inc.
Common Stock
S - Sale -16,046 338,719 -4.52 5.96 -95,634 2,018,765
2022-10-11 2022-10-10 4 STIM Neuronetics, Inc.
Common Stock
S - Sale -76 354,765 -0.02 2.82 -214 1,000,437
2022-10-11 2022-10-07 4 STIM Neuronetics, Inc.
Common Stock
S - Sale -1,547 354,841 -0.43 2.93 -4,533 1,039,684
2022-07-11 2022-07-08 4 STIM Neuronetics, Inc.
Common Stock
S - Sale -2,746 356,388 -0.76 3.60 -9,886 1,282,997
2022-03-09 2022-03-08 4 STIM Neuronetics, Inc.
Common Stock
S - Sale -137 359,134 -0.04 3.14 -430 1,127,142
2022-03-09 2022-03-07 4 STIM Neuronetics, Inc.
Common Stock
S - Sale -11,489 359,271 -3.10 2.85 -32,730 1,023,491
2022-02-11 2022-02-09 4 STIM Neuronetics, Inc.
Common Stock
A - Award 166,562 370,760 81.57
2022-02-09 2022-02-08 4 STIM Neuronetics, Inc.
Common Stock
S - Sale -15 204,198 -0.01 3.27 -49 667,727
2022-02-09 2022-02-07 4 STIM Neuronetics, Inc.
Common Stock
S - Sale -4,716 204,213 -2.26 3.26 -15,393 666,531
2022-01-25 2022-01-24 4 STIM Neuronetics, Inc.
Common Stock
S - Sale -11,562 208,929 -5.24 3.52 -40,698 735,430
2021-10-06 2021-10-04 4 STIM Neuronetics, Inc.
Common Stock
A - Award 10,000 220,491 4.75
2021-07-09 2021-07-08 4 STIM Neuronetics, Inc.
Common Stock
S - Sale -2,591 210,491 -1.22 14.61 -37,860 3,075,716
2021-03-11 2021-03-09 4 STIM Neuronetics, Inc.
Common Stock
S - Sale -8,537 213,082 -3.85 14.65 -125,067 3,121,651
2021-02-05 2021-02-03 4 STIM Neuronetics, Inc.
Perfornance Restricted Stock Unit
A - Award 10,000 10,000
2021-02-05 2021-02-03 4 STIM Neuronetics, Inc.
Common Stock
A - Award 33,166 221,619 17.60
2021-01-25 2021-01-22 4 STIM Neuronetics, Inc.
Common Stock
S - Sale -12,696 188,453 -6.31 21.28 -270,171 4,010,280
2020-07-08 2020-07-07 4 STIM Neuronetics, Inc.
Common Stock
A - Award 18,750 201,149 10.28
2020-03-11 2020-03-10 4 STIM Neuronetics, Inc.
Common Stock
P - Purchase 5,000 182,399 2.82 2.00 10,000 364,798
2020-03-09 2020-03-05 4 STIM Neuronetics, Inc.
Common Stock
A - Award 76,250 177,399 75.38
2020-01-22 2020-01-21 4 STIM Neuronetics, Inc.
Common Stock
A - Award 101,149 101,149
2019-11-12 2019-11-08 4 SLCA U.S. SILICA HOLDINGS, INC.
Restricted Stock Unit
M - Exercise -6,945 13,888 -33.34
2019-11-12 2019-11-08 4 SLCA U.S. SILICA HOLDINGS, INC.
Common Stock
F - Taxes -2,732 41,006 -6.25 5.64 -15,408 231,274
2019-11-12 2019-11-08 4 SLCA U.S. SILICA HOLDINGS, INC.
Common Stock
M - Exercise 6,945 43,738 18.88
2019-02-14 2019-02-12 4 SLCA U.S. SILICA HOLDINGS, INC.
Common Stock
A - Award 36,793 36,793
2018-11-13 2018-11-08 4 SLCA U.S. SILICA HOLDINGS, INC.
Restricted Stock Units
A - Award 20,833 20,833
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)